Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?

Gastroenterology. 2002 Dec;123(6):2160-1. doi: 10.1053/gast.2002.37303.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Drug Therapy, Combination
  • Hepatorenal Syndrome / drug therapy*
  • Hepatorenal Syndrome / physiopathology*
  • Humans
  • Lypressin / analogs & derivatives*
  • Lypressin / therapeutic use*
  • Terlipressin
  • Vasoconstriction* / drug effects*
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Vasoconstrictor Agents
  • Lypressin
  • Terlipressin
  • Acetylcysteine